glp-1 agonists cancer risk receptor show anti-cancer benefits beyond weight loss Patients taking GLP-1 receptor agonists

Racial and genomic determinants In a nationwide retrospective cohort study, Tabernacki et al

The decision to scale back AOM coverage is likely less a commentary on the drugs clinical value and more a result of difficult budgetary considerations

If you take medications with a narrow therapeutic window such as levothyroxine, warfarin, or some seizure medications your physician may monitor levels more closely

Assessing the shadows: a meta-analysis of GLP-1 agonists and suicidal ideation

GLP-1 receptor agonists are a class of injectable and oral medications that mimic the natural incretin hormone, GLP-1

This is partly due to tirzepatide's mechanism of action as a double agonist, permitting it to assert a more significant decrease in hyperglycemia as compared to glucagon-like peptide (GLP-1) agonists on their own [8]